Conversion to Dysport in CD

Status Active, not recruiting

Clinical Trial Summary

The first line of therapy for cervical dystonia patients is botulinum toxin injections, however injection parameter determination and optimization are challenging for physicians to do. In addition, some patients receiving this treatment long-term experience short duration of relief. Thus, Dysport (Ipsen Biopharmaceuticals), another BoNT-A formulation, may increase the duration of clinical benefit. The objective of this study is to compare the wearing off time of their original BoNT-A formulation (same injection parameters for at least 3 cycles) and the optimized treatment of Dysport (after 2 injection cycles). Ideally, the clinical benefits should last 2.5 - 3 months as injections are administered every 3 months. Conversion to Dysport will be conducted and optimization of Dysport dosing will be done using our sensor-technology assessment. It is unclear whether there are differences in the neurophysiological effects between BoNT-A formulations, such as blocking spinal afferent signals from proprioceptive mechanoreceptors of the injected muscles contributing to CD or the modulation of cortical activity [8]. The underlying pathophysiology of impaired motor control in CD is theorized to be caused by abnormal somatosensory processing that affects proprioceptive and tactile function [8]. By altering the processing of proprioceptive signals from the muscles to the cortical somatosensory-motor areas, proprioceptive perception can be modulated and possibly normalize activity of the somatosensory-motor areas in CD. Thus, it is hypothesized that BoNT-A may indirectly modulate these cortical pathways and Dysport may have a longer modulatory effect to produce a longer lasting clinical response.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04270214
Study type	Interventional
Source	Western University, Canada
Contact
Status	Active, not recruiting
Phase	N/A
Start date	June 1, 2020
Completion date	October 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03617367` - Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)	Phase 3
Not yet recruiting	`NCT04057911` - A Trial of Non-invasive Stimulation in Cervical Dystonia	N/A
Withdrawn	`NCT02180139` - tDCS in Cervical Dystonia	N/A
Completed	`NCT00541905` - Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia	Phase 4
Unknown status	`NCT00418925` - Efficacy of Dronabinol for the Treatment of Cervical Dystonia	Phase 2
Not yet recruiting	`NCT05715138` - Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia	N/A
Completed	`NCT02959645` - Assessment of Brain Activities in Cervical Dystonia
Completed	`NCT02131467` - Safety and Tolerability of Perampanel in Cervical Dystonia	Phase 1/Phase 2
Completed	`NCT03805152` - Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia	Phase 3
Completed	`NCT04949594` - Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)
Recruiting	`NCT01664013` - The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients	Phase 4
Completed	`NCT00447772` - Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia	Phase 3
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT05157100` - Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia	Phase 4
Completed	`NCT00257660` - Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia	Phase 3
Completed	`NCT05103202` - Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
Terminated	`NCT00760318` - Keppra for Cervical Dystonia	Phase 2
Completed	`NCT00323765` - Plasticity in Cervical Dystonia	N/A
Completed	`NCT04171258` - Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia	Phase 1
Completed	`NCT04849988` - A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia	Phase 2